Literature DB >> 21723700

Readmission and length of stay after total hip arthroplasty in a national Medicare sample.

John S Vorhies1, Yun Wang, James Herndon, William J Maloney, James I Huddleston.   

Abstract

Evaluation of hospital readmissions after total hip arthroplasty may help improve patient safety and cost reduction. This study investigates the rates and reasons for readmission as well as length of hospital stay (LOS) for 1802 total hip arthroplasty patients from 2002 to 2007. Data were abstracted from the Medicare Patient Safety Monitoring System. The overall 30-day rate of readmission was 6.8%. There was no difference in readmission rate from 2002 to 2004 (7.1%) to 2005 to 2007 (6.3%) (odds ratio, 0.90; 95% confidence interval, 0.63-1.30; P = .58). The overall mean LOS was 4.2 ± 2.2 days. There was a significant reduction in LOS from 2002 to 2004 (4.4 ± 2.5 days) to 2005 to 2007 (3.8 ± 1.7 days) (odds ratio, 1.28; 95% confidence interval, 1.25-1.31; P < .0001). The most common causes for readmission were cardiac related. A reduction in LOS was not associated with an increase in the rate of readmission in this sample. Efforts to optimize cardiac status before discharge may lead to lower rates of readmission in the future.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21723700     DOI: 10.1016/j.arth.2011.04.036

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  23 in total

1.  Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?

Authors:  Elizabeth W Paxton; Maria C S Inacio; Jasvinder A Singh; Rebecca Love; Stefano A Bini; Robert S Namba
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

2.  CORR Insights (®): Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?

Authors:  Ville Remes
Journal:  Clin Orthop Relat Res       Date:  2015-05-21       Impact factor: 4.176

3.  Short-term complications have more effect on cost-effectiveness of THA than implant longevity.

Authors:  David W Shearer; Jiwon Youm; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2015-01-06       Impact factor: 4.176

4.  Rapid recovery protocols for primary total hip arthroplasty can safely reduce length of stay without increasing readmissions.

Authors:  Jeffrey B Stambough; Ryan M Nunley; Madelyn C Curry; Karen Steger-May; John C Clohisy
Journal:  J Arthroplasty       Date:  2015-01-23       Impact factor: 4.757

5.  In-Hospital Outcomes after Hemiarthroplasty versus Total Hip Arthroplasty for Isolated Femoral Neck Fractures.

Authors:  Timothy Voskuijl; Valentin Neuhaus; Ahmet Kinaci; Mark Vrahas; David Ring
Journal:  Arch Bone Jt Surg       Date:  2014-09-15

6.  The Need for a Step-up in Postoperative Medical Care is Predictable in Orthopedic Patients Undergoing Elective Surgery.

Authors:  Michael K Urban; Michele Mangini-Vendel; Stephen Lyman; Ting Jung Pan; Steven K Magid
Journal:  HSS J       Date:  2015-10-01

7.  The Impact of Pre-Operative Healthcare Utilization on Complications, Readmissions, and Post-Operative Healthcare Utilization Following Total Joint Arthroplasty.

Authors:  Ashley E Creager; Andrew D Kleven; Ziynet Nesibe Kesimoglu; Austin H Middleton; Meaghan N Holub; Serdar Bozdag; Adam I Edelstein
Journal:  J Arthroplasty       Date:  2021-11-15       Impact factor: 4.757

8.  Variation in surgical-readmission rates and quality of hospital care.

Authors:  Thomas C Tsai; Karen E Joynt; E John Orav; Atul A Gawande; Ashish K Jha
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

9.  Readmission rates in the state of Florida: a reflection of quality?

Authors:  Carlos J Lavernia; Jesus M Villa; David A Iacobelli
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

10.  Outpatient total shoulder arthroplasty: A cost-identification analysis.

Authors:  M E Steinhaus; S S Shim; N Lamba; E C Makhni; R K Kadiyala
Journal:  J Orthop       Date:  2018-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.